These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Galanin and galanin antagonists: molecular and biochemical perspectives. Bartfai T; Fisone G; Langel U Trends Pharmacol Sci; 1992 Aug; 13(8):312-7. PubMed ID: 1384214 [TBL] [Abstract][Full Text] [Related]
5. Galanin--10 years with a neuroendocrine peptide. Bedecs K; Berthold M; Bartfai T Int J Biochem Cell Biol; 1995 Apr; 27(4):337-49. PubMed ID: 7540497 [TBL] [Abstract][Full Text] [Related]
7. Galanin, galanin receptors, and drug targets. Mitsukawa K; Lu X; Bartfai T Exp Suppl; 2010; 102():7-23. PubMed ID: 21299058 [TBL] [Abstract][Full Text] [Related]
8. Galanin expression within the basal forebrain in Alzheimer's disease. Comments on therapeutic potential. Mufson EJ; Kahl U; Bowser R; Mash DC; Kordower JH; Deecher DC Ann N Y Acad Sci; 1998 Dec; 863():291-304. PubMed ID: 9928179 [TBL] [Abstract][Full Text] [Related]
9. The alpha2-adrenergic receptor is more effective than the galanin receptor in activating G-proteins in RINm5F beta-cell membranes. Gillison SL; Straub SG; Sharp GW Diabetes; 1997 Mar; 46(3):401-7. PubMed ID: 9032095 [TBL] [Abstract][Full Text] [Related]
11. Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes. Bartfai T; Langel U; Bedecs K; Andell S; Land T; Gregersen S; Ahrén B; Girotti P; Consolo S; Corwin R Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11287-91. PubMed ID: 7504301 [TBL] [Abstract][Full Text] [Related]
12. Minireview. Galanin-acetylcholine interactions: relevance to memory and Alzheimer's disease. Crawley JN Life Sci; 1996; 58(24):2185-99. PubMed ID: 8649205 [TBL] [Abstract][Full Text] [Related]
13. Differential intracellular signaling of the GalR1 and GalR2 galanin receptor subtypes. Wang S; Hashemi T; Fried S; Clemmons AL; Hawes BE Biochemistry; 1998 May; 37(19):6711-7. PubMed ID: 9578554 [TBL] [Abstract][Full Text] [Related]
14. Galanin and its receptors in neurological disorders. Lundström L; Elmquist A; Bartfai T; Langel U Neuromolecular Med; 2005; 7(1-2):157-80. PubMed ID: 16052044 [TBL] [Abstract][Full Text] [Related]
15. Role of the third cytoplasmic loop in signal transduction by galanin receptors. Saar K; Valkna A; Soomets U; Rezaei K; Zorko M; Zilmer M; Langel U Biochem Soc Trans; 1997 Aug; 25(3):1036-40. PubMed ID: 9388597 [No Abstract] [Full Text] [Related]
16. Galanin: a biologically active peptide. Vrontakis ME Curr Drug Targets CNS Neurol Disord; 2002 Dec; 1(6):531-41. PubMed ID: 12769595 [TBL] [Abstract][Full Text] [Related]
18. Receptors for gut regulatory peptides. Laburthe M; Couvineau A; Amiranoff B; Voisin T Baillieres Clin Endocrinol Metab; 1994 Jan; 8(1):77-110. PubMed ID: 7510949 [TBL] [Abstract][Full Text] [Related]
19. Galanin and 5-HT1A receptor interactions as an integrative mechanism in 5-HT neurotransmission in the brain. Hedlund PB; Fuxe K Ann N Y Acad Sci; 1996 Mar; 780():193-212. PubMed ID: 8602734 [No Abstract] [Full Text] [Related]
20. Mutagenesis and ligand modification studies on galanin binding to its GTP-binding-protein-coupled receptor GalR1. Berthold M; Kahl U; Juréus A; Kask K; Nordvall G; Langel U; Bartfai T Eur J Biochem; 1997 Oct; 249(2):601-6. PubMed ID: 9370372 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]